Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 12: Tetracyclines: tetracycline, chlortetracycline, oxytetracycline, and doxycycline

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Dokumenter

  • EFSA Panel on Biological Hazards (BIOHAZ)
  • Konstantinos Koutsoumanis
  • Ana Allende
  • Avelino Alvarez-Ordóñez
  • Declan Bolton
  • Sara Bover-Cid
  • Marianne Chemaly
  • Robert Davies
  • Alessandra De Cesare
  • Lieve Herman
  • Friederike Hilbert
  • Roland Lindqvist
  • Maarten Nauta
  • Giuseppe Ru
  • Marion Simmons
  • Panagiotis Skandamis
  • Elisabetta Suffredini
  • Dan I Andersson
  • Vasileios Bampidis
  • Johan Bengtsson-Palme
  • Damien Bouchard
  • Aude Ferran
  • Maryline Kouba
  • Secundino López Puente
  • Marta López-Alonso
  • Alena Pechová
  • Mariana Petkova
  • Sebastien Girault
  • Alessandro Broglia
  • Beatriz Guerra
  • Matteo Lorenzo Innocenti
  • Ernesto Liébana
  • Gloria López-Gálvez
  • Paola Manini
  • Pietro Stella
  • Luisa Peixe
Abstract The specific concentrations of tetracycline, chlortetracycline, oxytetracycline and doxycycline in non-target feed for food-producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. The FARSC for these four tetracyclines was estimated. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. Levels in feed that showed to have an effect on growth promotion/increased yield were reported for tetracycline, chlortetracycline, oxytetracycline, whilst for doxycycline no suitable data for the assessment were available. Uncertainties and data gaps associated with the levels reported were addressed. It was recommended to perform further studies to supply more diverse and complete data related to the requirements for calculation of the FARSC for these antimicrobials.
OriginalsprogEngelsk
Artikelnummere06864
TidsskriftEFSA Journal
Vol/bind19
Udgave nummer10
Sider (fra-til)1-116
Antal sider116
ISSN1831-4732
DOI
StatusUdgivet - 26 okt. 2021

ID: 282612419